PHARMA
Agilent Technologies Opens Lab For Traditional Chinese Medicine Testing
Agilent and Temasek Polytechnic have opened a new laboratory to study the safety and quality standards in traditional Chinese medicine and food products.
Protagonist Therapeutics Raises $14 Million in Series B Venture Financing
The University of Queensland spin-off Protagonist Therapeutics, Inc. has completed a US$14 million Series B venture financing initiative.
Otsuka, Lundbeck Present Lu AE58054 Phase II Data For Alzheimer’s Disease
H. Lundbeck A/S and Otsuka Pharma announced Phase II clinical data on their Lu AE58054 investigational drug for moderate Alzheimer's disease.
Luqa Pharma To Commercialize BMG Pharma’s Products In China
Chinese pharma Luqa Pharmaceuticals will commercialize BMG Pharma's products in China and Hong Kong.
Kinex Pharma To Lead Orascovery Program In China
Kinex Pharma will lead Hanmi Pharma's Orascovery program development in China.
Herpes Vaccine Clinical Trial To Begin In Brisbane
A University of Queensland spin-off company is about to start clinical trials that could result in the prevention and treatment of genital herpes.
Taiwan Vaccine Maker Completes PhIII Trials On H7N9 Influenza Vaccine
Taiwan-based vaccine maker Adimmune Corp says that it has the capacity to produce up to three million units per month of its preliminary H7N9 influenza vaccine.
Soligenix, SciClone To Collaborate On Oral Mucositis Drug For Chinese Market
Soligenix, Inc. will collaborate with SciClone Pharmaceuticals in China on its oral mucositis drug candidate, SGX942.
Japan Approves World’s First Transdermal Beta-Blocker Patch
Toa Eiyo Ltd. has received manufacturing and marketing authorization in Japan for its transdermal Bisono® beta-blocker tape.
